Patent: 7,838,524
✉ Email this page to a colleague
Summary for Patent: 7,838,524
Title: | Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
Abstract: | The present invention relates to compounds of formula (I), pharmaceutical compositions which contain them and methods for treating cancer using compounds of formula (I). ##STR00001## |
Inventor(s): | Lee; Wendy (South San Francisco, CA), Ladouceur; Gaetan (Guilford, CT), Dumas; Jacques (Waltham, MA), Smith; Roger (Madison, CT), Ying; Shihong (Orange, CT), Wang; Gan (Wallingord, CT), Chen; Zhi (Lyndhurst, NJ), Liu; Qingjie (Orange, CT), Mokdad; Holia Hatoum (Guilford, CT) |
Assignee: | Bayer Healthcare LLC (Tarrytown, NY) |
Application Number: | 11/579,093 |
Patent Claims: | see list of patent claims |
Details for Patent 7,838,524
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | 06/21/1989 | ⤷ Try a Trial | 2024-04-30 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2024-04-30 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2024-04-30 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2024-04-30 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |